Structuring of a Lung Cancer Screening Program Including Clinical, Radiological and Biological Phenotyping Useful for the Development of Individualized Risk Prediction Tools: PREVALUNG ETOILE

Clinical trial NCT05649046 · UNKNOWN

Trial details

NCT number: NCT05649046
Sponsor: Assistance Publique Hopitaux De Marseille
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Smoking-related Pathology Atheroma Chronic Bronchitis Non-progressive Cancer > 5 Years Lung Cancer

Start date: 2023-01-23
Primary completion: 2024-06-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.